Apyx Medical (APYX) Income towards Parent Company (2011 - 2026)

Apyx Medical has reported Income towards Parent Company for 15 years, with the latest figure at -$2.1 million in Q1 2026.

• For the quarter ending Q1 2026, Income towards Parent Company rose 48.63% year-over-year to -$2.1 million; the trailing twelve-month figure through Mar 2026 stood at $4.8 million (down 14.98% YoY), and the FY2025 full-year result was $2.8 million, up 24.83% from the prior year.
• Income towards Parent Company for Q1 2026 stood at -$2.1 million, down from $12.6 million in the prior quarter.
• The five-year high for Income towards Parent Company was $21.1 million in Q4 2024, with the low at -$9.6 million in Q4 2023.
• Historically, Income towards Parent Company has averaged -$2.3 million across 5 years, with a median of -$4.7 million in 2023.
• The largest YoY upside for Income towards Parent Company was 319.27% in 2024 against a maximum downside of 546.32% in 2024.
• Apyx Medical's Income towards Parent Company stood at -$6.1 million in 2022, then sank by 58.68% to -$9.6 million in 2023, then soared by 319.27% to $21.1 million in 2024, then sank by 40.22% to $12.6 million in 2025, then plunged by 116.99% to -$2.1 million in 2026.
• The last three Income towards Parent Company figures came in at -$2.1 million (Q1 2026), $12.6 million (Q4 2025), and -$2.0 million (Q3 2025), per Business Quant data.